ABBV-744 NO FURTHER A MYSTERY

Compound 60 has a very higher affinity to MDM2 (Ki < one nM), strong cellular action, and an excellent oral pharmacokinetic profile. Compound 60 is capable of obtaining comprehensive and extended-Long lasting tumor regression in vivo and is also at the moment in phase I scientific trials for most cancers treatment method.In an effort to facilitate